Capula Management Ltd Takes Position in Colgate-Palmolive (NYSE:CL)

Capula Management Ltd acquired a new stake in Colgate-Palmolive (NYSE:CL - Free Report) in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 4,116 shares of the company's stock, valued at approximately $374,000.

Several other hedge funds and other institutional investors have also recently bought and sold shares of the company. Kohmann Bosshard Financial Services LLC acquired a new position in shares of Colgate-Palmolive in the 4th quarter valued at $26,000. Centricity Wealth Management LLC acquired a new position in Colgate-Palmolive in the fourth quarter valued at about $27,000. Union Bancaire Privee UBP SA purchased a new position in Colgate-Palmolive during the fourth quarter worth about $32,000. Briaud Financial Planning Inc acquired a new stake in shares of Colgate-Palmolive during the fourth quarter valued at about $32,000. Finally, Wintrust Investments LLC purchased a new stake in shares of Colgate-Palmolive in the 4th quarter valued at approximately $33,000. 80.41% of the stock is currently owned by institutional investors and hedge funds.

Colgate-Palmolive Stock Up 2.4 %

NYSE:CL traded up $2.19 during trading hours on Friday, hitting $93.99. The company's stock had a trading volume of 5,664,216 shares, compared to its average volume of 4,582,305. Colgate-Palmolive has a 52-week low of $85.32 and a 52-week high of $109.30. The company has a current ratio of 0.92, a quick ratio of 0.58 and a debt-to-equity ratio of 13.40. The stock has a market capitalization of $76.24 billion, a P/E ratio of 26.70, a price-to-earnings-growth ratio of 4.20 and a beta of 0.40. The stock has a fifty day moving average of $90.48 and a 200-day moving average of $92.57.

Remove Ads

Colgate-Palmolive (NYSE:CL - Get Free Report) last released its quarterly earnings data on Friday, January 31st. The company reported $0.91 EPS for the quarter, beating analysts' consensus estimates of $0.90 by $0.01. Colgate-Palmolive had a return on equity of 477.77% and a net margin of 14.38%. During the same period in the prior year, the company posted $0.87 EPS. On average, equities analysts forecast that Colgate-Palmolive will post 3.75 earnings per share for the current year.

Colgate-Palmolive declared that its board has approved a share buyback plan on Thursday, March 20th that authorizes the company to repurchase $5.00 billion in outstanding shares. This repurchase authorization authorizes the company to purchase up to 6.8% of its shares through open market purchases. Shares repurchase plans are generally a sign that the company's board of directors believes its stock is undervalued.

Colgate-Palmolive Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, May 15th. Stockholders of record on Thursday, April 17th will be given a dividend of $0.52 per share. This represents a $2.08 annualized dividend and a dividend yield of 2.21%. The ex-dividend date is Thursday, April 17th. This is an increase from Colgate-Palmolive's previous quarterly dividend of $0.50. Colgate-Palmolive's payout ratio is currently 59.09%.

Analysts Set New Price Targets

CL has been the subject of several research reports. TD Cowen dropped their target price on shares of Colgate-Palmolive from $110.00 to $100.00 and set a "buy" rating for the company in a report on Wednesday, January 8th. UBS Group dropped their price objective on Colgate-Palmolive from $104.00 to $100.00 and set a "buy" rating for the company in a research note on Monday, February 3rd. Barclays decreased their target price on Colgate-Palmolive from $89.00 to $86.00 and set an "equal weight" rating on the stock in a research note on Friday. JPMorgan Chase & Co. dropped their target price on Colgate-Palmolive from $99.00 to $95.00 and set an "overweight" rating for the company in a research report on Friday. Finally, StockNews.com raised shares of Colgate-Palmolive from a "hold" rating to a "buy" rating in a research report on Friday, April 4th. One investment analyst has rated the stock with a sell rating, nine have given a hold rating and twelve have assigned a buy rating to the company's stock. According to data from MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and an average target price of $101.67.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.